Robotic Prostate Surgery Cost in India

One of the most effective techniques for the treatment of prostate cancer is robotic radical prostatectomy. It has a high success rate and is carried out in the safest and most effective manner possible. In India, surgery success rates range from 90 to 98 percent.

The cost of a robotic radical prostatectomy operation starts at $6500 in India.

Depending on the size, architecture, and constitution of the prostate, as well as the length of operation required, the robotic prostatectomy often takes 2 to 4 hours or more.

After robotic prostatectomy surgery, most patients are able to return home the next day or in two days.

Patients can usually return to their normal activities 14 to 21 days after surgery. Heavy lifting and intense activity should be avoided for the first four weeks after surgery. The majority of robotic prostatectomy patients are able to return to work within 3-4 weeks of the procedure.

Patients who have been told they need surgery for prostate cancer are usually good candidates for robotic prostatectomy. Open prostatectomy is a minimally invasive surgery that usually produces great results for those who are suitable.

A urinary catheter is required to ensure proper urine drainage from the bladder and to aid in the healing of the operated area. It is frequently necessary for a week or two following surgery.

The da Vinci Surgical System is currently in use in hundreds of places throughout the world, including major institutions in India, Malaysia, Thailand, and the United Arab Emirates.

The following are some of the primary advantages that surgeons who use the da Vinci Surgical System have over traditional approaches:

• More precise surgical procedures
• Range of motion has been increased
• Dexterity has improved

Approximately 1.5 million procedures including general, urologic, gynecologic, thoracoscopic, and thoracoscopically-assisted cardiotomy procedures have been performed using the da Vinci Surgical System.

Do not eat or drink anything for at least 8 hours before the surgery. To clean the bowels, you may be advised to take laxatives or an enema before the treatment. Some medications should be avoided for ten days before surgery. Aspirin, warfarin, vitamins, and anti-inflammatory medications are among them.

The high-tech equipment used to perform the surgery is one of the key benefits of robotic prostatectomy.

First, the employment of a specialized stereoscopic endoscope lens attached to a high definition camera improves visualization with 10-12 X magnification and a high resolution image of the inside anatomy.

Second, robotic surgeons use multi-jointed 8 mm devices with dexterity comparable to a human wrist. When combined, robotic surgery improves visualization of the critical structures surrounding the prostate gland and allows surgeons to operate with the same flexibility and ease as an open surgeon when performing an open prostatectomy, all while using smaller incisions and resulting in significantly less blood loss.

If trouble with dissection or severe bleeding is found with the robotic method, conversion to open surgery may be required. Our surgeons are trained in both open and laparoscopic surgery, as well as robotic surgery, and are thus well equipped to complete the procedure in either a laparoscopic or open manner as necessary.

Prognosis remains excellent for individuals with organ-confined prostate cancer that has not progressed beyond the prostate capsule, lymph nodes, or seminal vesicles, as most are treated with surgery alone. Additional treatments, including radiation and hormone therapy, may be required if more invasive or metastatic illness is discovered.

The timing and extent of urine continence and sexual potency after prostatectomy is a complex, time-dependent, and multifaceted process. Patient characteristics such as age, preoperative urine and sexual function, and the existence of medical disorders such as hypertension and diabetes are some of the factors that determine the success of the return of these quality of life concerns. Surgical parameters such as the quality and quantity of nerve preservation can also have an impact on the result.

Research shows that at 6 and 12 months, respectively, 80 percent and 93 percent of young patients (60 years old) who were preoperatively potent with no urinary issues and received bilateral nerve preservation were continent (defined as 0-1 security pad) and 72 percent and 85 percent were potent (defined as having the ability to engage in intercourse with or without the use of phosphodiesterase inhibitor medications). Individual factors, such as the amount of cancer, age, and concomitant medical disorders, can have a substantial impact on these outcomes.